Organogenesis hits 9-month high over BTIG rating upgrade

Integra LifeSciences Holdings

24/05/2023 17:50

** Shares of advanced wound care & surgical medicines co
Organogenesis Holdings Inc  ORGO.O  rise 17.7% to $4.05, hitting
9- months high
    ** Brokerage BTIG raises ORGO stock rating to "buy" from
"neutral" with PT of $10
    ** Adds that combination of better-than-expected Q1 results,
improving market dynamics and co's knee osteoarthritis product,
ReNu in clinical stage to benefit co
    ** Says unexpected competitor challenges create
earlier-than-expected opportunity for co
    ** After Integra LifeSciences'  IART.O  voluntary recall of
its tissue products, BTIG sees a chance for co capturing 
meaningful share in surgical reconstruction market over the rest
of the year
    ** Nearly 2 mln shares change hands, more than 1.6 times the
stock's 25-day moving avg volume
    ** Including session's gains, stock has risen 50.74% YTD

 (Reporting by Sruthi Narasimha Chari in Bengaluru)
 ((Sruthinarasimha.chari@thomsonreuters.com))